Keith Wilson

Keith Wilson has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as VP of CMC and Manufacturing at both Amal Therapeutics and Boehringer Ingelheim since February 2021. Prior to this, Keith held the position of Independent Biotech Consultant at Keith Wilson Biotech Consulting and was the Global Head of Pharmaceutical Development at Sobi from July 2019 to February 2021. Keith's prior roles include Head of Biopharmaceutical Development and Supply and Head of Bioprocess R&D at NovImmune, along with leadership positions in analytical development at Lonza and GlaxoSmithKline. Keith holds a PhD in Biochemistry from the University of Essex and a Bachelor's degree in Cellular and Molecular Biology.